Isolation of monoclonal antibodies from anti-synthetase syndrome patients and affinity maturation by recombination of independent somatic variants

Luke Burmana Discovery Biology, aTyr Pharma, San Diego, CA, USACorrespondence[email protected]

Yeeting E. Chonga Discovery Biology, aTyr Pharma, San Diego, CA, USA

Sherie Duncanb AbCellera Biologics Inc., Vancouver, BC, Canada

Anders Klausb AbCellera Biologics Inc., Vancouver, BC, Canada

Kaitlyn Raucha Discovery Biology, aTyr Pharma, San Diego, CA, USA

Kristina Hamela Discovery Biology, aTyr Pharma, San Diego, CA, USA

Karine Hervéb AbCellera Biologics Inc., Vancouver, BC, Canada

Stephanie Pfaffenb AbCellera Biologics Inc., Vancouver, BC, Canada

David W. Collinsb AbCellera Biologics Inc., Vancouver, BC, Canada

Kevin Heyriesb AbCellera Biologics Inc., Vancouver, BC, Canada

Leslie Nanglea Discovery Biology, aTyr Pharma, San Diego, CA, USA

Carl Hansenb AbCellera Biologics Inc., Vancouver, BC, Canada

David J. Kinga Discovery Biology, aTyr Pharma, San Diego, CA, USA

Your download is now in progress and you may close this window